Hypnosis in Gastrointestinal System Diseases

Abstract

Hypnosis, which is directed towards one's own subconscious mind, has recently become an increasingly used treatment method in gastrointestinal diseases. The aim of this review is to determine the gastrointestinal system diseases in which hypnosis is effective. Among the diseases in which hypnosis can be effective, functional dyspepsia, nausea and vomiting due to chemotherapy, chronic idiopathic nausea, hyperemesis gravidarum, eating disorders, irritable bowel syndrome and inflammatory bowel diseases are shown.

Keywords

• Hypnosis,gastrointestinal system diseases,clinical application

Gastrointestinal Sistem Hastalıklarında Hipnoz

Abstract

Kişinin bilinçaltının kendi isteği doğrultusunda yönlendirilmesi olan hipnoz, gastrointestinal hastalıklarda son zamanlarda kullanımı giderek artan bir tedavi yöntemi haline gelmiştir. Bu derleme ile hipnozun etkin olduğu gastrointestinal sistem hastalıklarının ortaya konulması amaçlanmıştır. Hipnozun etkili olabileceği hastalıklar arasında; fonksiyonel dispepsi, kemoterapiye bağlı bulantı ve kusma, kronik idyopatik bulantı, hiperemezis gravidarum, yeme bozuklukları, irritabl bağırsak sendromu ve inflamatuar bağırsak hastalıkları gösterilebilir.

Keywords

• Hipnoz,gastrointestinal sistem hastalıkları,klinik uygulama

References

1. Vasant DH, Whorwell PJ. Gut-focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence-base, practical aspects, and the Manchester Protocol. Neurogastroenterol Motil. 2019 Aug;31(8):e13573.
2. Ballou S, Keefer L. The impact of irritable bowel syndrome on daily functioning: Characterizing and understanding daily consequences of IBS. Neurogastroenterol Motil. 2017;29(4):e12982.
3. Frändemark Å, Törnblom H, Jakobsson S, Simrén M. Work productivity and activity impairment in irritable bowel syndrome (IBS): a multifaceted problem. Am J Gastroenterol. 2018;113: 1540‐1549.
4. Taştan K, Çayır Y, Makas YN, Set T, Hülakü A, Tekşan T. Atatürk Üniversitesi Tıp Fakültesi’nde çalışan doktorların hipnoterapi ile ilgili görüşleri, eğitim durumları ve bilgi edinme kaynakları. Smyrna Tıp Dergisi, 2015, 2:1-6.
5. Set T, Taştan K. Hipnoz ve aile hekimliğinde kullanımı. Turkiye Klinikleri Family Medicine-Special Topics, 2012, 3.1: 56-58.
6. Elkins GR, Barabasz AF, Council JR, Spiegel D. Advancing research and practice: the revised APA Division 30 definition of hypnosis. Int J Clin Exp Hypn. 2015;63(1):1-9.
7. Shenefelt PD. Mindfulness-Based Cognitive Hypnotherapy and Skin Disorders. Am J Clin Hypn. 2018 Jul;61(1):34-44.
8. Chiu L, Lee HW, Lam WK. The Effectiveness of Hypnotherapy in the Treatment of Chinese Psychiatric Patients. Int J Clin Exp Hypn. 2018 Jul-Sep;66(3):315-330.

9. Tastan K, Ozer Disci O, Set T. A Comparison of the Efficacy of Acupuncture and Hypnotherapy in Patients With Migraine. Int J Clin Exp Hypn. 2018 Oct-Dec;66(4):371-385.
10. Riehl ME, Pandolfino JE, Palsson OS, Keefer L. Feasibility and acceptability of esophageal‐directed hypnotherapy for functional heartburn. Dis Esophagus. 2016;29(5):490‐496.
11. Jones H, Cooper P, Miller V, Brooks N, Whorwell PJ. Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy. Gut. 2006 Oct;55(10):1403-8.
12. Miller V, Jones H, Whorwell PJ. Hypnotherapy for non-cardiac chest pain: long-term follow-up. Gut. 2007 Nov;56(11):1643.
13. Kiebles JL, Kwiatek MA, Pandolfino JE, Kahrilas PJ, Keefer L. Do patients with globus sensation respond to hypnotically assisted relaxation therapy? A case series report. Dis Esophagus. 2010 Sep;23(7):545-53.
14. Popa SL, Chiarioni G, David L, Dumitrascu DL. The Efficacy of Hypnotherapy in the Treatment of Functional Dyspepsia. Am J Ther. 2019 Nov/Dec;26(6):e704-e713.
15. Shankar A, Roy S, Malik A, Julka PK, Rath GK. Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients. Asian Pac J Cancer Prev. 2015;16(15):6207-13.
16. Marchioro G, Azzarello G, Viviani F, Barbato F, Pavanetto M, Rosetti F, et al. Hypnosis in the treatment of anticipatory nausea and vomiting in patients receiving cancer chemotherapy. Oncology. 2000 Aug;59(2):100-4.
17. Richardson J, Smith JE, McCall G, Richardson A, Pilkington K, Kirsch I. Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence. Eur J Cancer Care (Engl). 2007;16(5):402-12.
18. Kravits KG. Hypnosis for the Management of Anticipatory Nausea and Vomiting. J Adv Pract Oncol. 2015;6(3):225-9.
19. Taştan K, Demiröz HP, Öztekin C, Sincan S. Bulimia Nervoza Tedavisinde Hipnoterapi: Olgu Sunumu. CausaPedia 2017; 6(2): 94-97.
20. Browne PD, den Hollander B, Speksnijder EM, van Wering HM, Tjon A Ten W, George EK, et al. Gut-directed hypnotherapy versus standard medical treatment for nausea in children with functional nausea or functional dyspepsia: protocol of a multicentre randomised trial. BMJ Open. 2019 Apr 11;9(4):e024903.
21. Emami-Sahebi A, Elyasi F, Yazdani-Charati J, Shahhosseini Z. Psychological interventions for nausea and vomiting of pregnancy: A systematic review. Taiwan J Obstet Gynecol. 2018 Oct;57(5):644-649.
22. Vasant DH, Whorwell PJ. Gut-focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence-base, practical aspects, and the Manchester Protocol. Neurogastroenterol Motil. 2019 Aug;31(8):e13573.
23. Peters SL, Yao CK, Philpott H, Yelland GW, Muir JG, Gibson PR. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2016;44(5):447-59.
24. Moser G, Trägner S, Gajowniczek EE, Mikulits A, Michalski M, Kazemi-Shirazi L, et al. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol. 2013 Apr;108(4):602-9.
25. Simon RA, Engström M, Icenhour A, Lowén M, Ström M, Tillisch K, et al. On Functional Connectivity and Symptom Relief After Gut-directed Hypnotherapy in Irritable Bowel Syndrome: A Preliminary Study. J Neurogastroenterol Motil. 2019 Jul 1;25(3):478-479.
26. Shahbazi K, Solati K, Hasanpour-Dehkordi A. Comparison of Hypnotherapy and Standard Medical Treatment Alone on Quality of Life in Patients with Irritable Bowel Syndrome: A Randomized Control Trial. J Clin Diagn Res. 2016 May;10(5):OC01-4.
27. Miller V, Carruthers HR, Morris J, Hasan SS, Archbold S, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients. Aliment Pharmacol Ther. 2015;41(9):844‐855.
28. Flik CE, Laan W, Zuithoff NPA, van Rood YR, Smout AJPM, Weusten BLAM, et al. Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol. 2019 Jan;4(1):20-31.
29. Rutten JM, Vlieger AM, Frankenhuis C, George EK, Groeneweg M, Norbruis OF, et al. Gut-directed hypnotherapy in children with irritable bowel syndrome or functional abdominal pain (syndrome): a randomized controlled trial on self exercises at home using CD versus individual therapy by qualified therapists. BMC Pediatr. 2014 Jun 4;14:140.
30. Rutten J, Reitsma JB, Vlieger AM, Benninga MA. Gut‐directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review. Arch Dis Child. 2013;98(4):252‐257.
31. Szigethy E. Hypnotherapy for Inflammatory Bowel Disease Across the Lifespan. Am J Clin Hypn. 2015 Jul;58(1):81-99.
32. Moser G. The role of hypnotherapy for the treatment of inflammatory bowel diseases. Expert Rev Gastroenterol Hepatol. 2014 Aug;8(6):601-6.
33. Keefer L, Taft TH, Kiebles JL, Martinovich Z, Barrett TA, Palsson OS. Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther. 2013 Oct;38(7):761-71.
34. Greifenegg M, Michalski M, Dejaco C, Moser G. Gut directed hypnosis for patients with inflammatory bowel diseases (IBD). Psychother Psychosom 2013;82(suppl 1):39
35. Peter JM, Tran US, Michalski M, Moser G. Irritable bowel syndrome and psychological comorbidity – long-term success of gut-directed group hypnosis. Psychother Psychosom 2013;82(suppl 1):84.